Three gene therapy pioneers just won the Breakthrough Prize. This is their story

Ryan Cross / endpoints - A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field ...

AI Summary: Three gene‑therapy researchers received the Breakthrough Prize in recognition of foundational work that enabled the first CRISPR-based sickle cell therapy. The award highlights decades of basic and translational research that turned genome editing from lab curiosity into a tangible clinical remedy, with winners sharing a multimillion‑dollar prize and public acclaim.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 6 wks

The peptide problem: Hype outruns evidence, researchers caution / 22 days

Mid‑stage Parkinson trial failure halts drug development plans / 8 days

FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 13 days

Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 15 days

First‑in‑human CRISPR/Cas12a sickle cell therapy treated; gene editing shows promise / 1 month

Denali drug receives accelerated approval for rare CNS indication / 2 months